278 related articles for article (PubMed ID: 26781029)
1. Approaches for Designing new Potent Inhibitors of Farnesyl Pyrophosphate Synthase.
Rodriguez JB; Falcone BN; Szajnman SH
Expert Opin Drug Discov; 2016; 11(3):307-20. PubMed ID: 26781029
[TBL] [Abstract][Full Text] [Related]
2. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN
J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033
[TBL] [Abstract][Full Text] [Related]
3. Antiparasitic Activity of Sulfur- and Fluorine-Containing Bisphosphonates against Trypanosomatids and Apicomplexan Parasites.
Galaka T; Ferrer Casal M; Storey M; Li C; Chao MN; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
Molecules; 2017 Jan; 22(1):. PubMed ID: 28054995
[TBL] [Abstract][Full Text] [Related]
4. Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.
Gabelli SB; McLellan JS; Montalvetti A; Oldfield E; Docampo R; Amzel LM
Proteins; 2006 Jan; 62(1):80-8. PubMed ID: 16288456
[TBL] [Abstract][Full Text] [Related]
5. Digeranyl bisphosphonate inhibits geranylgeranyl pyrophosphate synthase.
Wiemer AJ; Tong H; Swanson KM; Hohl RJ
Biochem Biophys Res Commun; 2007 Feb; 353(4):921-5. PubMed ID: 17208200
[TBL] [Abstract][Full Text] [Related]
6. Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development.
Dhar MK; Koul A; Kaul S
N Biotechnol; 2013 Jan; 30(2):114-23. PubMed ID: 22842101
[TBL] [Abstract][Full Text] [Related]
7. New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase.
Ferrer-Casal M; Li C; Galizzi M; Stortz CA; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
Bioorg Med Chem; 2014 Jan; 22(1):398-405. PubMed ID: 24300918
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the catalytic mechanism of farnesyl pyrophosphate synthase by computer simulation.
Sanchez VM; Crespo A; Gutkind JS; Turjanski AG
J Phys Chem B; 2006 Sep; 110(36):18052-7. PubMed ID: 16956297
[TBL] [Abstract][Full Text] [Related]
9. Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010).
Sun S; McKenna CE
Expert Opin Ther Pat; 2011 Sep; 21(9):1433-51. PubMed ID: 21702715
[TBL] [Abstract][Full Text] [Related]
10. Increasing the intracellular isoprenoid pool in Saccharomyces cerevisiae by structural fine-tuning of a bifunctional farnesyl diphosphate synthase.
Rubat S; Varas I; Sepúlveda R; Almonacid D; González-Nilo F; Agosin E
FEMS Yeast Res; 2017 Jun; 17(4):. PubMed ID: 28854674
[TBL] [Abstract][Full Text] [Related]
11. Farnesyl pyrophosphate synthase is essential for the promastigote and amastigote stages in Leishmania major.
Mukherjee S; Basu S; Zhang K
Mol Biochem Parasitol; 2019 Jun; 230():8-15. PubMed ID: 30926449
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis.
Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of farnesyl pyrophosphate synthase from parasitic protozoa, a potential chemotherapeutic target.
Srivastava A; Mukherjee P; Desai PV; Avery MA; Tekwani BL
Infect Disord Drug Targets; 2008 Mar; 8(1):16-30. PubMed ID: 18473904
[TBL] [Abstract][Full Text] [Related]
14. Two Eucommia farnesyl diphosphate synthases exhibit distinct enzymatic properties leading to end product preferences.
Kajiura H; Suzuki N; Tokumoto Y; Yoshizawa T; Takeno S; Fujiyama K; Kaneko Y; Matsumura H; Nakazawa Y
Biochimie; 2017 Aug; 139():95-106. PubMed ID: 28478108
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.
Rosso VS; Szajnman SH; Malayil L; Galizzi M; Moreno SN; Docampo R; Rodriguez JB
Bioorg Med Chem; 2011 Apr; 19(7):2211-7. PubMed ID: 21419634
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and characterization of non-bisphosphonate quinoline derivatives as new FPPS inhibitors.
Liu J; Liu W; Ge H; Gao J; He Q; Su L; Xu J; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Mar; 1840(3):1051-62. PubMed ID: 24246954
[TBL] [Abstract][Full Text] [Related]
17. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
[TBL] [Abstract][Full Text] [Related]
18. Identifying Structural Determinants of Product Specificity in
Maheshwari S; Kim YS; Aripirala S; Murphy M; Amzel LM; Gabelli SB
Biochemistry; 2020 Jul; 59(29):2751-2759. PubMed ID: 32584028
[TBL] [Abstract][Full Text] [Related]
19. Fragment-Based Discovery of Non-bisphosphonate Binders of Trypanosoma brucei Farnesyl Pyrophosphate Synthase.
Münzker L; Petrick JK; Schleberger C; Clavel D; Cornaciu I; Wilcken R; Márquez JA; Klebe G; Marzinzik A; Jahnke W
Chembiochem; 2020 Nov; 21(21):3096-3111. PubMed ID: 32537808
[TBL] [Abstract][Full Text] [Related]
20. Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates.
Aripirala S; Gonzalez-Pacanowska D; Oldfield E; Kaiser M; Amzel LM; Gabelli SB
Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):802-10. PubMed ID: 24598749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
